Schott launches InJentle syringe to improve drug stability
Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.
Speaking to in-PharmaTechnologist at Pharmapack 2010, Gregor Dudek, director, product management pharmaceutical packaging at Schott, explained that the syringe is designed to prevent the drug coming into contact with potential contaminants.
The syringe also has a tamper-evident closure and can be modified to include additional anti-counterfeiting features, such as radiofrequency identification (RFID) tags.
Additionally, sharper ‘virgin’ needles are used to make the injection less painful for patients. Particularly thin, siliconised needles can also be used to improve patient application.